Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
medtechdive2d
Abbott ramps up Libre 3 production amid shortages
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
Neurology Devices Market Review and Forecast 2020-2030 Featuring Abbott Labs, Zimmer Biomet, Medtronic, Stryker, Integra Lifesciences
The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...
Abbott Laboratories stock underperforms Wednesday when compared to competitors
The stock's fall snapped a two-day winning streak.
Law4d
Who Got the Work: O'Melveny Set to Defend Abbott Labs in Digital Privacy Class Action
O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other co-defendants, ...
Wells Fargo Remains a Buy on Medtronic (MDT)
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...
Abbott Laboratories (ABT) Gets a Buy from Wells Fargo
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...